Anita Immanuel1, Jane Hunt1, Helen McCarthy2, Edwin van Teijlingen1,3,4, Zoë A Sheppard5. 1. Faculty of Health & Social Sciences, Bournemouth University, Bournemouth, UK. 2. Royal Bournemouth Hospital, Bournemouth, UK. 3. MMIHS, Tribhuvan University, Kirtipur, Nepal. 4. Nobel College, Pokhara University, Lekhnath, Nepal. 5. Research and Innovation, Dorset County Hospital, Dorchester, UK.
Abstract
BACKGROUND: Survivors of haematological malignancies endure long-term effects of both treatment and disease. This paper examines factors that influence their quality of life through reporting on the results of a survey. METHODS: Survey using previously validated quality of life questionnaires for use in cancer management. Participants were adults aged 18 and over who had completed treatment for a haematological malignancy and were between 1 and 5 years post-treatment. FINDINGS: A total of 131 participants, median age of 66, completed questionnaires (66% response rate). Significant associations were found between age, global quality of life, physical and role functioning. Men reported better physical functioning and lower symptom scores than women. Employed participants reported better quality of life. Increasing age was associated with lowest quality of life. Best role functioning was also noted in participants who lived beyond 2.5 years following treatment completion. The survey suggested a gender difference with men reporting better physical functioning, fewer symptoms of pain and less loss of sleep compared with women. CONCLUSION: This study contributes to the underdeveloped area of care for and research into adult haematological cancer survivors. Knowledge and understanding of the factors that affect the quality of life of such adults may provide an insight into implementation measures.
BACKGROUND: Survivors of haematological malignancies endure long-term effects of both treatment and disease. This paper examines factors that influence their quality of life through reporting on the results of a survey. METHODS: Survey using previously validated quality of life questionnaires for use in cancer management. Participants were adults aged 18 and over who had completed treatment for a haematological malignancy and were between 1 and 5 years post-treatment. FINDINGS: A total of 131 participants, median age of 66, completed questionnaires (66% response rate). Significant associations were found between age, global quality of life, physical and role functioning. Men reported better physical functioning and lower symptom scores than women. Employed participants reported better quality of life. Increasing age was associated with lowest quality of life. Best role functioning was also noted in participants who lived beyond 2.5 years following treatment completion. The survey suggested a gender difference with men reporting better physical functioning, fewer symptoms of pain and less loss of sleep compared with women. CONCLUSION: This study contributes to the underdeveloped area of care for and research into adult haematological cancer survivors. Knowledge and understanding of the factors that affect the quality of life of such adults may provide an insight into implementation measures.
Authors: Micha J Pilz; Eva-Maria Gamper; Fabio Efficace; Juan I Arraras; Sandra Nolte; Gregor Liegl; Matthias Rose; Johannes M Giesinger Journal: BMC Public Health Date: 2022-05-24 Impact factor: 4.135